Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial (Q34494637)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial |
scientific article |
Statements
1 reference
Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial (English)
1 reference
Julio Rosenstock
1 reference
Louis J Aronne
1 reference
F Xavier Pi-Sunyer
1 reference
Hassan M Heshmati
1 reference
Jeanne Devin
1 reference
RIO-North America Study Group
1 reference
1 February 2006
1 reference
1 reference
295
1 reference
7
1 reference
761-775
1 reference
Identifiers
1 reference
1 reference